These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23941963)

  • 1. Karyotypically abnormal human ESCs are sensitive to HDAC inhibitors and show altered regulation of genes linked to cancers and neurological diseases.
    Lund RJ; Emani MR; Barbaric I; Kivinen V; Jones M; Baker D; Gokhale P; Nykter M; Lahesmaa R; Andrews PW
    Stem Cell Res; 2013 Nov; 11(3):1022-36. PubMed ID: 23941963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.
    Stubbs MC; Kim W; Bariteau M; Davis T; Vempati S; Minehart J; Witkin M; Qi J; Krivtsov AV; Bradner JE; Kung AL; Armstrong SA
    Clin Cancer Res; 2015 May; 21(10):2348-58. PubMed ID: 25688158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of HDAC1 in E-cadherin expression in prostate cancer cells; its implication for cell motility and invasion.
    Kim NH; Kim SN; Kim YK
    Biochem Biophys Res Commun; 2011 Jan; 404(4):915-21. PubMed ID: 21184735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of the tumor suppressor C-terminal Src kinase (Csk)-binding protein (Cbp)/PAG1 is mediated by epigenetic histone modifications via the mitogen-activated protein kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K) pathway.
    Suzuki K; Oneyama C; Kimura H; Tajima S; Okada M
    J Biol Chem; 2011 May; 286(18):15698-706. PubMed ID: 21388951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance.
    Santoro F; Botrugno OA; Dal Zuffo R; Pallavicini I; Matthews GM; Cluse L; Barozzi I; Senese S; Fornasari L; Moretti S; Altucci L; Pelicci PG; Chiocca S; Johnstone RW; Minucci S
    Blood; 2013 Apr; 121(17):3459-68. PubMed ID: 23440245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibition with valproic acid downregulates osteocalcin gene expression in human dental pulp stem cells and osteoblasts: evidence for HDAC2 involvement.
    Paino F; La Noce M; Tirino V; Naddeo P; Desiderio V; Pirozzi G; De Rosa A; Laino L; Altucci L; Papaccio G
    Stem Cells; 2014 Jan; 32(1):279-89. PubMed ID: 24105979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation.
    Zupkovitz G; Grausenburger R; Brunmeir R; Senese S; Tischler J; Jurkin J; Rembold M; Meunier D; Egger G; Lagger S; Chiocca S; Propst F; Weitzer G; Seiser C
    Mol Cell Biol; 2010 Mar; 30(5):1171-81. PubMed ID: 20028735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC Inhibitor-Induced Mitotic Arrest Is Mediated by Eg5/KIF11 Acetylation.
    Nalawansha DA; Gomes ID; Wambua MK; Pflum MKH
    Cell Chem Biol; 2017 Apr; 24(4):481-492.e5. PubMed ID: 28392145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation.
    Frumm SM; Fan ZP; Ross KN; Duvall JR; Gupta S; VerPlank L; Suh BC; Holson E; Wagner FF; Smith WB; Paranal RM; Bassil CF; Qi J; Roti G; Kung AL; Bradner JE; Tolliday N; Stegmaier K
    Chem Biol; 2013 May; 20(5):713-25. PubMed ID: 23706636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between karyotypically normal and abnormal human embryonic stem cells.
    Yang S; Lin G; Tan YQ; Deng LY; Yuan D; Lu GX
    Cell Prolif; 2010 Jun; 43(3):195-206. PubMed ID: 20546238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for histone deacetylase 1 in human tumor cell proliferation.
    Senese S; Zaragoza K; Minardi S; Muradore I; Ronzoni S; Passafaro A; Bernard L; Draetta GF; Alcalay M; Seiser C; Chiocca S
    Mol Cell Biol; 2007 Jul; 27(13):4784-95. PubMed ID: 17470557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins.
    Pang M; Ma L; Liu N; Ponnusamy M; Zhao TC; Yan H; Zhuang S
    J Cell Biochem; 2011 Aug; 112(8):2138-48. PubMed ID: 21465537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte histone deacetylase activity regulates murine and human glomerular diseases.
    Inoue K; Gan G; Ciarleglio M; Zhang Y; Tian X; Pedigo CE; Cavanaugh C; Tate J; Wang Y; Cross E; Groener M; Chai N; Wang Z; Justice A; Zhang Z; Parikh CR; Wilson FP; Ishibe S
    J Clin Invest; 2019 Mar; 129(3):1295-1313. PubMed ID: 30776024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.
    Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park H; Lee JY; Nam SW
    J Cell Biochem; 2012 Jun; 113(6):2167-77. PubMed ID: 22492270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulatory effect of ginsenoside Rh2 on HDAC1/2 activity and cyclin in human erythroleukemia K562 cells].
    Xia J; Chen D; Zuo G; Wei Q; You Z; Li D; Liu Z; Li J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1062-6. PubMed ID: 25270209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of p21waf1/cip1 expression in the cytotoxicity of the potent histone deacetylase inhibitor spiruchostatin B towards susceptible NALM-6 human B cell leukemia cells.
    Kanno S; Maeda N; Tomizawa A; Yomogida S; Katoh T; Ishikawa M
    Int J Oncol; 2012 May; 40(5):1391-6. PubMed ID: 22211246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors.
    Sacco JJ; Kenyani J; Butt Z; Carter R; Chew HY; Cheeseman LP; Darling S; Denny M; Urbé S; Clague MJ; Coulson JM
    Oncotarget; 2015 May; 6(15):13757-71. PubMed ID: 25970771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells.
    Hrzenjak A; Moinfar F; Kremser ML; Strohmeier B; Staber PB; Zatloukal K; Denk H
    Mol Cancer Ther; 2006 Sep; 5(9):2203-10. PubMed ID: 16985053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.